Webinar on Trade Secret and Access to Medicine by CUSAT and Third World Network [Sep 22, 7-8:30 PM]: Register Now!




The DPIIT IPR Chair of Inter University Centre for IPR Studies, Cochin University of Science and Technology and Third World Network are jointly organizing a Webinar on Trade Secret and Access to Medicine on September 22, 2021. 

About the Topic of the Webinar

Intellectual property seeks to achieve certain objectives such as disclosure, dissemination of information and creation of innovations. However, trade
secrets though being considered as an IP does not fulfil some of these objectives. The use of such a property right in areas where the public interest is
largely involved carries huge implications.

The pharmaceutical sector is one such industry where trade secrets have been used to veil information that is vital to the general public. When these rights get imbibed in binding international instruments like the TRIPS agreement, it becomes more difficult for countries with less bargaining power to shape their public policies according to their domestic interests.

Trade secret is the prime reason behind vaccine and biotherapeutic monopoly, which is currently manifested as COVID19 vaccine inequity. Intellectual property, especially trade secrets are seen as the biggest hurdle in this context and therefore requires appropriate checks and balances.

In this context, the DPIIT Chair on IPR of the Inter University Centre for IPR Studies, CUSAT and the Third World Network (TWN) are organising a webinar
to discuss about the protection afforded to trade secrets and the public interest involved in it.

Details of the Webinar

Date and Time: September 22, 2021 from 7 PM to 8:30 PM

Topic: Trade Secret and Access to Medicine

Zoom Link: https://lawc.to/ZAppy

About the Speakers

David S. Levine, Elon University School of Law: Trade Secrets and Public Policy

K.M. Gopakumar, Third World Network: Trade Secrets and Access to COVID-19 Drugs

Moderator: Naveen Gopal, DPIIT IPR Chair, Inter University Centre for IPR Studies, CUSAT